Ldr Holding Corp Cmn (LDRH) 36.98 $LDRH
MedTech Tailwinds at a Glance: Which Stocks to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 5:02PM CDT
MedTech Tailwinds at a Glance: Which Stocks to Buy?
ABMD: 117.97 (+2.94), LDRH: 36.98 (-0.02), MDT: 87.63 (+0.21), PAHC: 20.63 (-0.26), MLAB: 115.63 (-3.92), NUVA: 62.20 (+0.18), BSX: 24.28 (-0.06), BABY: 39.33 (-0.24), SNN: 33.29 (+0.64), JNJ: 125.23 (+0.77), DXCM: 92.23 (+2.67), GWPH: 94.32 (unch), RMD: 68.88 (+3.18), WOOF: 71.34 (+0.25), ABT: 44.75 (+0.30), VIVO: 19.36 (-0.64), MASI: 52.97 (+0.39), TMO: 158.84 (+0.02), CYH: 12.77 (-0.34), HTWR: 57.94 (+0.05), FEIC: 106.42 (+0.12), ISRG: 695.76 (+5.67), CFMS: 6.97 (-0.06), STE: 70.95 (+0.62), STJ: 83.04 (+0.38), XRAY: 64.04 (+0.94), HOLX: 38.49 (+0.22)
Medical Device Consolidation Frenzy: Here's How to Play it
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:00AM CDT
The medical device majors struggling with their core businesses are often on the lookout for emerging therapies through acquisitions and alliances.
ABT: 44.75 (+0.30), JNJ: 125.23 (+0.77), ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02), MDT: 87.63 (+0.21), TMO: 158.84 (+0.02), STJ: 83.04 (+0.38), HTWR: 57.94 (+0.05), XRAY: 64.04 (+0.94), NUVA: 62.20 (+0.18), FEIC: 106.42 (+0.12)
Empirical Capital Management Sends Letter to LDR Holding Corp. Board of Directors Regarding the Inadequacy of the Proposed Offer From Zimmer Biomet, Inc.
ACCESSWIRE - Tue Jun 21, 7:30AM CDT
HENDERSONVILLE, TN / ACCESSWIRE / June 20, 2016 / Empirical Capital Management is writing regarding Zimmer Biomet's June 6, 2016 announcement of a tender offer to acquire LDR Holding Corporation. Empirical began accumulating shares of LDRH on February 10, 2014, and has since transacted 140 additional purchases of the stock. Empirical Capital Partners LP. owns 446,441 shares of LDRH, or approximately 1.5% of the company.
LDRH: 36.98 (-0.02)
LDR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of LDR Holding Corporation (LDRH) Over the Proposed Sale of the Company to Zimmer Biomet Holdings, Inc.
PR Newswire - Wed Jun 15, 10:18AM CDT
Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of LDR Holding Corporation ("LDR" or the "Company"
(NASDAQ:LDRH) for potential breaches of fiduciary duties in connection with the sale of the Company to Zimmer Biomet Holdings, Inc. for approximately $1.0 billion.
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal Securities Laws
PR Newswire - Tue Jun 14, 8:11AM CDT
The Law Offices of Marc S. Henzel (www.henzellaw.com), a firm focusing on shareholder litigation, gives notice to shareholders of investigation into the following securities for violations of the Federal Securities Laws:
LDRH: 36.98 (-0.02), CBL: 12.29 (+1.31), TRXC: 1.35 (+0.04), EGRX: 43.14 (-1.62), NVCN: 0.54 (+0.02)
INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of LDR Holding Corporation And Encourages Shareholders To Contact The Firm For Additional Information
BusinessWire - Mon Jun 13, 6:00PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of LDR Holding Corporation (NASDAQ: LDRH) ("LDR" or the "Company" relating to the proposed buyout of LDR by Zimmer Biomet Holdings, Inc.
LDRH: 36.98 (-0.02)
LDR Holding Corp. Acquisition May Not Be in the Best Interests of LDRH Shareholders
PR Newswire - Thu Jun 09, 2:06PM CDT
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of LDR Holding Corp. ("LDRH" or the "Company" in connection with the proposed acquisition of the Company by Zimmer Biomet Holdings Inc. ("Zimmer Biomet". On June 7, 2016, the Company announced it had reached a definitive agreement for Zimmer Biomet to acquire all outstanding shares of LDRH in a transaction valued at approximately $1 billion. Under the terms of the agreement, LDRH shareholders will receive $37.00 in cash for each LDRH share they own.
LDRH: 36.98 (-0.02)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH
PR Newswire - Thu Jun 09, 10:20AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
LDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Is $37.00 a Fair Price?
PR Newswire - Wed Jun 08, 7:14PM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached their fiduciary duties in connection with the proposed sale of the Company to Zimmer Biomet Holdings, Inc. (NYSE: ZBH).
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
LDR HOLDING CORPORATION SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by Zimmer Biomet Holdings, Inc. May be Unfair to Shareholders
BusinessWire - Wed Jun 08, 12:05PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of LDR Holding Corporation ("LDR" (NASDAQ: LDRH) concerning the acquisition by Zimmer Biomet Holdings, Inc. Under the terms of the agreement, valued at approximately $1 billion, LDR shareholders will only receive $37.00 per LDR share owned. The consideration is significantly lower than at least one analyst's estimated value of $40.00.
LDRH: 36.98 (-0.02)
Zimmer Biomet's Spine Business to Get a Boost with LDR Buy
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) has entered into a definitive agreement to acquire LDR Holding Corp. (LDRH) for a total deal value of $1 billion.
BSX: 24.28 (-0.06), ICUI: 116.76 (+0.71), ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of LDR Holding Corporation And Encourages Investors To Contact The Firm For Additional Information
BusinessWire - Tue Jun 07, 4:25PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of LDR Holding Corporation (NASDAQ: LDRH) ("LDR" or the "Company" relating to the proposed buyout of LDR by Zimmer Biomet Holdings, Inc.
LDRH: 36.98 (-0.02)
Harwood Feffer LLP Announces Investigation of LDR Holding Corporation
PR Newswire - Tue Jun 07, 2:21PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of LDR Holding Corporation ("LDR" or the "Company" (NASDAQ: LDRH) concerning the proposed acquisition of the Company by Zimmer Biomet Holdings, Inc. ("Zimmer".
LDRH: 36.98 (-0.02)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH
ACCESSWIRE - Tue Jun 07, 10:19AM CDT
NEW YORK, NY / ACCESSWIRE / June 7, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
LDR HOLDING CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Tue Jun 07, 9:28AM CDT
Rigrodsky & Long, P.A.:
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
Zimmer buying LDR for $1 billion
AP - Tue Jun 07, 8:04AM CDT
NEW YORK (AP) — Zimmer Biomet will spend $1 billion to acquire medical device maker buy LDR Holding Corp., strengthening its position in the spine disorder surgical technology business.
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
LDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Are Shareholders Getting a Fair Price?
PR Newswire - Tue Jun 07, 7:13AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached their fiduciary duties in connection with the proposed sale of the Company to Zimmer Biomet Holdings, Inc. (NYSE: ZBH).
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
Zimmer Biomet to Acquire LDR to Enhance Innovation and Growth of Spine Business
GlobeNewswire - Tue Jun 07, 6:05AM CDT
-- Significantly Expands Portfolio of Innovative Solutions for $10 Billion Spine Market
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
Zimmer Biomet To Acquire LDR To Enhance Innovation And Growth Of Spine Business
PR Newswire - Tue Jun 07, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (Zimmer Biomet or the Company), a global leader in musculoskeletal healthcare, and LDR Holding Corporation (NASDAQ: LDRH) (LDR), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that both Boards of Directors have approved a definitive agreement under which Zimmer Biomet will commence a tender offer to acquire all of the outstanding shares of LDR for $37.00 per share in cash, which implies a transaction value of approximately $1.0 billion. The transaction is subject to customary closing conditions and is expected to close in the third quarter of 2016.
ZMH: 113.56 (+0.29), ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
LDR Announces First Surgeries Using ROI-C Cervical Cage With Titanium Coating
GlobeNewswire - Thu Jun 02, 3:05PM CDT
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced the initial implantations of the ROI-C Titanium-Coated Cervical Cage. The first surgeries were performed by Dr. Mark Giovanini, a board-certified neurosurgeon specializing in minimally invasive spine surgery in Pensacola, Florida, and Dr. Neil Romero, a board-certified orthopedic surgeon specializing in minimally invasive spine surgery and arthroplasty in Lafayette, Louisiana.
LDRH: 36.98 (-0.02)
MedTech Tailwinds at a Glance: Which Stocks to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 5:02PM CDT
MedTech Tailwinds at a Glance: Which Stocks to Buy?
ABMD: 117.97 (+2.94), LDRH: 36.98 (-0.02), MDT: 87.63 (+0.21), PAHC: 20.63 (-0.26), MLAB: 115.63 (-3.92), NUVA: 62.20 (+0.18), BSX: 24.28 (-0.06), BABY: 39.33 (-0.24), SNN: 33.29 (+0.64), JNJ: 125.23 (+0.77), DXCM: 92.23 (+2.67), GWPH: 94.32 (unch), RMD: 68.88 (+3.18), WOOF: 71.34 (+0.25), ABT: 44.75 (+0.30), VIVO: 19.36 (-0.64), MASI: 52.97 (+0.39), TMO: 158.84 (+0.02), CYH: 12.77 (-0.34), HTWR: 57.94 (+0.05), FEIC: 106.42 (+0.12), ISRG: 695.76 (+5.67), CFMS: 6.97 (-0.06), STE: 70.95 (+0.62), STJ: 83.04 (+0.38), XRAY: 64.04 (+0.94), HOLX: 38.49 (+0.22)
Medical Device Consolidation Frenzy: Here's How to Play it
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:00AM CDT
The medical device majors struggling with their core businesses are often on the lookout for emerging therapies through acquisitions and alliances.
ABT: 44.75 (+0.30), JNJ: 125.23 (+0.77), ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02), MDT: 87.63 (+0.21), TMO: 158.84 (+0.02), STJ: 83.04 (+0.38), HTWR: 57.94 (+0.05), XRAY: 64.04 (+0.94), NUVA: 62.20 (+0.18), FEIC: 106.42 (+0.12)
Empirical Capital Management Sends Letter to LDR Holding Corp. Board of Directors Regarding the Inadequacy of the Proposed Offer From Zimmer Biomet, Inc.
ACCESSWIRE - Tue Jun 21, 7:30AM CDT
HENDERSONVILLE, TN / ACCESSWIRE / June 20, 2016 / Empirical Capital Management is writing regarding Zimmer Biomet's June 6, 2016 announcement of a tender offer to acquire LDR Holding Corporation. Empirical began accumulating shares of LDRH on February 10, 2014, and has since transacted 140 additional purchases of the stock. Empirical Capital Partners LP. owns 446,441 shares of LDRH, or approximately 1.5% of the company.
LDRH: 36.98 (-0.02)
LDR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of LDR Holding Corporation (LDRH) Over the Proposed Sale of the Company to Zimmer Biomet Holdings, Inc.
PR Newswire - Wed Jun 15, 10:18AM CDT
Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of LDR Holding Corporation ("LDR" or the "Company"
(NASDAQ:LDRH) for potential breaches of fiduciary duties in connection with the sale of the Company to Zimmer Biomet Holdings, Inc. for approximately $1.0 billion. ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal Securities Laws
PR Newswire - Tue Jun 14, 8:11AM CDT
The Law Offices of Marc S. Henzel (www.henzellaw.com), a firm focusing on shareholder litigation, gives notice to shareholders of investigation into the following securities for violations of the Federal Securities Laws:
LDRH: 36.98 (-0.02), CBL: 12.29 (+1.31), TRXC: 1.35 (+0.04), EGRX: 43.14 (-1.62), NVCN: 0.54 (+0.02)
INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of LDR Holding Corporation And Encourages Shareholders To Contact The Firm For Additional Information
BusinessWire - Mon Jun 13, 6:00PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of LDR Holding Corporation (NASDAQ: LDRH) ("LDR" or the "Company"
relating to the proposed buyout of LDR by Zimmer Biomet Holdings, Inc. LDRH: 36.98 (-0.02)
LDR Holding Corp. Acquisition May Not Be in the Best Interests of LDRH Shareholders
PR Newswire - Thu Jun 09, 2:06PM CDT
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of LDR Holding Corp. ("LDRH" or the "Company"
in connection with the proposed acquisition of the Company by Zimmer Biomet Holdings Inc. ("Zimmer Biomet". On June 7, 2016, the Company announced it had reached a definitive agreement for Zimmer Biomet to acquire all outstanding shares of LDRH in a transaction valued at approximately $1 billion. Under the terms of the agreement, LDRH shareholders will receive $37.00 in cash for each LDRH share they own. LDRH: 36.98 (-0.02)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH
PR Newswire - Thu Jun 09, 10:20AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
LDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Is $37.00 a Fair Price?
PR Newswire - Wed Jun 08, 7:14PM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached their fiduciary duties in connection with the proposed sale of the Company to Zimmer Biomet Holdings, Inc. (NYSE: ZBH).
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
LDR HOLDING CORPORATION SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by Zimmer Biomet Holdings, Inc. May be Unfair to Shareholders
BusinessWire - Wed Jun 08, 12:05PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of LDR Holding Corporation ("LDR"
(NASDAQ: LDRH) concerning the acquisition by Zimmer Biomet Holdings, Inc. Under the terms of the agreement, valued at approximately $1 billion, LDR shareholders will only receive $37.00 per LDR share owned. The consideration is significantly lower than at least one analyst's estimated value of $40.00. LDRH: 36.98 (-0.02)
Zimmer Biomet's Spine Business to Get a Boost with LDR Buy
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) has entered into a definitive agreement to acquire LDR Holding Corp. (LDRH) for a total deal value of $1 billion.
BSX: 24.28 (-0.06), ICUI: 116.76 (+0.71), ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of LDR Holding Corporation And Encourages Investors To Contact The Firm For Additional Information
BusinessWire - Tue Jun 07, 4:25PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of LDR Holding Corporation (NASDAQ: LDRH) ("LDR" or the "Company"
relating to the proposed buyout of LDR by Zimmer Biomet Holdings, Inc. LDRH: 36.98 (-0.02)
Harwood Feffer LLP Announces Investigation of LDR Holding Corporation
PR Newswire - Tue Jun 07, 2:21PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of LDR Holding Corporation ("LDR" or the "Company"
(NASDAQ: LDRH) concerning the proposed acquisition of the Company by Zimmer Biomet Holdings, Inc. ("Zimmer". LDRH: 36.98 (-0.02)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH
ACCESSWIRE - Tue Jun 07, 10:19AM CDT
NEW YORK, NY / ACCESSWIRE / June 7, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
LDR HOLDING CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Tue Jun 07, 9:28AM CDT
Rigrodsky & Long, P.A.:
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
Zimmer buying LDR for $1 billion
AP - Tue Jun 07, 8:04AM CDT
NEW YORK (AP) — Zimmer Biomet will spend $1 billion to acquire medical device maker buy LDR Holding Corp., strengthening its position in the spine disorder surgical technology business.
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
LDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Are Shareholders Getting a Fair Price?
PR Newswire - Tue Jun 07, 7:13AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached their fiduciary duties in connection with the proposed sale of the Company to Zimmer Biomet Holdings, Inc. (NYSE: ZBH).
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
Zimmer Biomet to Acquire LDR to Enhance Innovation and Growth of Spine Business
GlobeNewswire - Tue Jun 07, 6:05AM CDT
-- Significantly Expands Portfolio of Innovative Solutions for $10 Billion Spine Market
ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
Zimmer Biomet To Acquire LDR To Enhance Innovation And Growth Of Spine Business
PR Newswire - Tue Jun 07, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (Zimmer Biomet or the Company), a global leader in musculoskeletal healthcare, and LDR Holding Corporation (NASDAQ: LDRH) (LDR), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that both Boards of Directors have approved a definitive agreement under which Zimmer Biomet will commence a tender offer to acquire all of the outstanding shares of LDR for $37.00 per share in cash, which implies a transaction value of approximately $1.0 billion. The transaction is subject to customary closing conditions and is expected to close in the third quarter of 2016.
ZMH: 113.56 (+0.29), ZBH: 131.14 (+3.67), LDRH: 36.98 (-0.02)
LDR Announces First Surgeries Using ROI-C Cervical Cage With Titanium Coating
GlobeNewswire - Thu Jun 02, 3:05PM CDT
LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced the initial implantations of the ROI-C Titanium-Coated Cervical Cage. The first surgeries were performed by Dr. Mark Giovanini, a board-certified neurosurgeon specializing in minimally invasive spine surgery in Pensacola, Florida, and Dr. Neil Romero, a board-certified orthopedic surgeon specializing in minimally invasive spine surgery and arthroplasty in Lafayette, Louisiana.
LDRH: 36.98 (-0.02)
